跳到主要导航 跳到搜索 跳到主要内容

Economic burden of human papilloma virus related diseases in China: a systematic review and synthetic analysis

  • Ni Nan He
  • , Zhuo Ru Zou
  • , Yun Bo Zhang
  • , Xiao Qing He
  • , Su Qiang Xiong
  • , Chang Xin Liu
  • , Jia Wei Bao
  • , Ru Yi Xia
  • , Gui Hua Zhuang
  • Xi'an Jiaotong University
  • Key Laboratory for Disease Prevention and Control and Health Promotion of Shaanxi Province

科研成果: 期刊稿件文章同行评审

10 引用 (Scopus)

摘要

Objective To integrate cost-related data of human papilloma virus (HPV) related diseases from Mainland China and estimate the economic burden. Methods We uesd "Cost/expense" combined with names of the nine major HPV-related diseases, i.e. cervical cancer, vaginal cancer, vulva cancer, anal cancer, penile cancer, oropharyngeal cancer, cervical intraepithelial neoplasia (CIN), ano- genital warts (AGW), and recurrent respiratory papillomatosis (RRP), as keywords. Seven databases in- cluding PubMed and China National Knowledge Infrastructure were selected, for literature targeting pa-tients in mainland China published between 2001-2020. Various cost-related data were extracted, and cost data were adjusted annually to 2020 according to appropriate consumer price indices. Data were used to estimate per-capita direct medical costs, direct non-medical costs, and indirect costs for each of the nine diseases. The incidence, prevalence, and HPV attribution fraction of each of the nine diseases were collected to further estimate the total economic burden of HPV-related diseases in Mainland China in 2020. Results A total of 247 articles were included. Annual per-capita total costs of each of the six cancers ranged from 58 189 to 79 567 yuan in the first year of the disease and from 13 025 to 27 965 yuan in each subsequent year. Annual per-capita total costs of RRP were 41 329 yuan. Per-capita total costs of CIN and AGW ranged between 6 452 and 13 602 yuan. The total economic burden due to HPV-related diseases in Mainland China in 2020 was about 18. 03 billion yuan, with cervical cancer accounting for 9.69 billion yuan. Direct medical costs were a significant part of the economic burden, accounting for 70% of the total burden, with 7.0 billion yuan in direct medical costs due to cervical cancer. Conclu- sions The annual economic burden of HPV-related diseases in Mainland China cannot be ignored. Scal- ing up HPV vaccination is needed to reduce associated economic losses.

源语言英语
页(从-至)345-351
页数7
期刊Chinese Journal of Disease Control and Prevention
27
3
DOI
出版状态已出版 - 29 4月 2023
已对外发布

联合国可持续发展目标

此成果有助于实现下列可持续发展目标:

  1. 可持续发展目标 3 - 良好健康与福祉
    可持续发展目标 3 良好健康与福祉

学术指纹

探究 'Economic burden of human papilloma virus related diseases in China: a systematic review and synthetic analysis' 的科研主题。它们共同构成独一无二的学术指纹。

引用此